首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1684437

免疫血液學市場，按類型、按應用、按最終用戶、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測

Immunohematology Market, By Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: 2025年02月04日 | 出版商:

AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

報告重點

2024 年免疫血液學市場規模價值 26.0943 億美元，2025 年至 2032 年期間複合年成長率為 7.82%。

免疫血液學市場-市場動態

免疫血液學市場受到血液疾病和慢性病發病率增加的推動。根據世界衛生組織統計，全球約有16.2億人患有貧血。這些案例強調了先進的血液檢測和輸血服務的重要性。此外，全球外科手術數量的增加也增加了對血液製品和免疫血液學服務的需求。提高意識和政府推動捐血的措施增加了血液製品的供應，從而刺激了市場擴張。結合次世代定序和聚合酶鏈反應 (PCR) 提高了免疫血液學診斷的準確性，從而鼓勵其在臨床環境中得到更廣泛的應用。

新興市場對免疫血液學產業具有巨大的成長潛力。發展中國家對醫療保健基礎設施的投資將用於改善診斷和輸血服務。此外，隨著個人化醫療和針對患者的血液管理方法的日益普及，專門的免疫血液學產品和服務在市場上找到了發展空間。公私合作提高捐血意識和安全標準也將有利於市場成長。然而，先進診斷設備的高成本以及操作複雜診斷儀器的高技能人員可能會阻礙市場的發展。此外，有關血液製品和診斷設備的規定通常非常嚴格，通常會延遲產品註冊和進入市場，可能影響新解決方案的及時上市。

免疫血液學市場-關鍵見解

試劑是市場上最大的細分市場，因為它們在血型分型和交叉配血中用途廣泛，原因之一是市場對優質、可靠試劑的需求不斷成長。

醫院是免疫血液學市場最大的組成部分，因為醫院擁有現代化的診斷設施和熟練的人員，可以為患者進行複雜的免疫血液學測試。

北美憑藉著更完善的醫療保健結構、更多的輸血程序以及頂級競爭對手的領導地位引領市場。

由於衛生系統的不斷改善、民眾捐血意識的提高以及衛生技術投資的推動，亞太地區成長最快。

免疫血液學市場-細分分析：

全球免疫血液學市場根據類型、應用、最終用戶和地區進行細分。

根據類型，免疫血液學市場分為分析儀和試劑。試劑部分佔據市場主導地位。血型鑑定、交叉配血和篩檢過程依賴試劑；從而獲得了統治權。患者群體中血液疾病發生率的增加以及輸血頻率的增加，對血庫試劑盒的依賴要求越來越高，試劑盒的準確度也越來越高。這些試劑在醫院、血庫和診斷實驗室中被廣泛使用，以確保輸血的兼容性並治療溶血性疾病，凸顯了這些試劑的重要性。預計預測期內分析儀部分將成長最快。這是因為對於在血液檢測過程中提供更好的精度、更快的周轉時間和更有效率的工作流程的自動和半自動分析儀的需求不斷成長。全球實驗室自動化趨勢是推動分析儀領域成長的最重要因素之一。

根據最終用途，免疫血液學市場分為血庫、醫院、診斷和參考實驗室以及學術和研究機構。醫院是免疫血液學市場最大的部分。這是因為醫院在病患照護中至關重要，在手術和創傷期間，血型鑑定、交叉配血和輸血服務通常至關重要。醫院還擁有現代化的診斷設備和熟練的人員，可以進行複雜的免疫血液學測試來管理患者。血庫部門預計在預測期內將呈現最高的複合年成長率。這主要是由於人們認知的提高和相關計劃鼓勵人們選擇自願捐獻，以及血庫和採集中心的擴大。血庫已變得不可避免，因為它們構成並維持著有保障的充足供應，並且需要在其運作中利用最新的免疫血液學技術來檢測感染並保持相容性。血庫的發展（尤其是第三世界國家的血庫）提高了安全輸血的普及率，進一步推動了市場的成長。

免疫血液學市場-地理洞察

北美市場佔據主導地位，佔有相當大的佔有率。醫療保健系統的先進基礎設施、技術的最大利用以及每年大量的輸血解釋了這裡的佔有率。根據美國疾病管制與預防中心記錄，美國每年平均輸血量約為 1,460 萬單位，顯示該地區對免疫血液學相關產品和服務的需求非常高。對這個市場做出貢獻的主要國家包括美國和加拿大，這兩個國家以完善的醫療保健體系和對醫療創新的持續投資而聞名。預計預測期內亞太地區將經歷最快的成長。這是由於醫療保健支出的增加、捐血意識的增強以及血液相關疾病的增加。印度和中國等國家最近改善了其衛生基礎設施和輸血服務，世界衛生組織觀察到此類變化正在增加。這些趨勢使中國、印度和日本等國家處於這個不斷成長的市場的前沿，並且很可能繼續在免疫血液學實踐方面取得很大進展。

免疫血液學市場-競爭格局：

全球免疫血液學市場競爭激烈，有少數關鍵參與者正在推動創新並擴大其市場足跡。市場領先的公司包括 Bio-Rad Laboratories, Inc.、Immucor、Ortho Clinical Diagnostics、Grifols 和 BD（Becton Dickinson），它們憑藉廣泛的產品組合和強大的分銷網路佔據了市場主導地位。這些參與者專注於開發先進的免疫血液學解決方案，例如自動分析儀、試劑和分子診斷，以提高診斷的準確性和效率。策略合作、合併和收購是擴大產品供應和滲透新興市場的常見策略。透過與醫療機構和血庫合作，公司還可以滿足亞太地區和拉丁美洲日益成長的市場需求。旨在開發新一代免疫血液學技術的研發投資增強了市場的競爭格局。這種動態環境可能會推動免疫血液學領域的進一步發展。

介紹
- 按地區分類的細分市場佔有率分析
北美洲
- 概述
- 北美免疫血液學主要製造商
- 北美市場規模及預測（按國家/地區）
- 北美市場規模和預測（按類型）
- 北美市場規模與預測，按應用分類
- 北美市場規模和預測（按最終用戶）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲免疫血液學主要製造商
- 歐洲市場規模及預測（按國家）
- 歐洲市場規模與預測（按類型）
- 歐洲市場規模和預測，按應用
- 歐洲市場規模和預測（按最終用戶）
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 瑞典
- 俄羅斯
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區免疫血液學主要製造商
- 亞太地區市場規模及預測（依國家/地區分類）
- 亞太地區市場規模及預測（按類型）
- 亞太地區市場規模及預測（按應用分類）
- 亞太地區市場規模及預測（依最終用戶）
- 中國
- 印度
- 日本
- 韓國
- 澳洲
- 印尼
- 泰國
- 菲律賓
- 亞太地區其他地區
拉丁美洲 (LATAM)
- 概述
- 拉丁美洲免疫血液學主要製造商
- 拉丁美洲市場規模及預測（按國家/地區）
- 拉丁美洲市場規模及預測（按類型）
- 拉丁美洲市場規模及預測（按應用分類）
- 拉丁美洲市場規模及預測（按最終用戶）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲 (MEA)
- 概述
- 中東和非洲免疫血液學主要製造商
- MEA 市場規模及預測（依國家/地區分類）
- MEA 市場規模和預測（按類型）
- MEA 市場規模及預測（按應用）
- MEA 市場規模和預測（按最終用戶）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 其他地區

第 11 章：免疫血液學產業主要供應商分析

競爭儀錶板
- Competitive Benchmarking
- Competitive Positioning
公司簡介
- Bio-Rad Laboratories, Inc.
- Immucor
- Ortho Clinical Diagnostics
- Grifols
- BD (Becton Dickinson)
- Hologic, Inc.
- Siemens Healthineers
- ThermoFisher
- Abbott
- Beckman Coulter, Inc.

第 12 章：360 度分析師視角

第 13 章：附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄

Product Code: ANV4745

REPORT HIGHLIGHT

Immunohematology Market size was valued at US$ 2,609.43 Million in 2024, expanding at a CAGR of 7.82% from 2025 to 2032.

Immunohematology, more often referred to as blood banking or transfusion medicine, is the area of hematology and immunology that studies antigens and antibodies related to blood. This is one of the most indispensable healthcare fields, mainly focused on the identification and compatibility of blood for transfusions, and understanding the disorders that might be associated with immune reactions in the blood. The general theme for this field refers to the detection, characterization, and clinical implications of blood group antigens and their corresponding antibodies. The immunohematology foundation lies in ABO and Rh blood group systems, which are critical for blood compatibility determination. Immunohematology tests entail cross-matching, screening irregular antibodies, and detecting antigens predisposing individuals to adverse reactions related to transfusions or pregnancy. Such includes the hemolytic disease of the fetus and the newborn. Modern medicine could hardly do without it since applying blood and other blood products guarantees the treatment of numerous diseases- from traumas and surgeries, through anemias, to chronic diseases.

Immunohematology Market- Market Dynamics

The immunohematology market is driven by increased incidence of hematological disorders and chronic diseases. According to the World Health Organization, anemia has affected around 1.62 billion people globally. Such cases emphasize the importance of advanced blood testing and transfusion services. Moreover, the increased number of surgical procedures worldwide contributes to the demand for blood products & immunohematology services. Propelling awareness and government initiatives promoting blood donation have increased the availability of blood products, thereby stimulating market expansion. Incorporating next-generation sequencing and polymerase chain reaction (PCR) has improved the accuracy of immunohematology diagnostics, encouraging increased adoption in clinical settings.

Emerging markets hold significant growth potential for the immunohematology industry. Developing countries' investment in healthcare infrastructure would be targeted towards improving diagnostics & blood transfusion services. Moreover, with the increasing popularity of personalized medicine and the patient-specific approach toward blood management, specialized immunohematology products and services can find a scope in the market. Public-private collaborations to increase blood donation awareness and safety standards will also favor market growth. However, the high costs for advanced diagnostic equipment and the highly skilled personnel operating complex diagnostic instruments will likely hinder the market. Furthermore, regulations often very stringent concerning blood products and diagnostic devices usually delay product registration and entry to the market, possibly affecting the prompt availability of new solutions.

Immunohematology Market- Key Insights

Reagents segment is the largest in the market, because of their immense usage in blood typing and cross-matching, one of the reasons being the growth in demand for quality and reliable reagents.

Hospitals are the largest segment of the immunohematology market since hospitals have modern diagnostic facilities and skilled personnel who can perform intricate immunohematology tests for patient management.

North America leads the market, based on a better-established healthcare structure, a more significant number of blood transfusion procedures, and leadership of top competition.

Asia Pacific is growing fastest due to continuous improvement in health systems, blood donation awareness among the population, and health technology investment push.

Immunohematology Market- Segmentation Analysis:

The Global Immunohematology Market is segmented on the basis of Type, Application, End User, and Region.

By type, the immunohematology market is divided into analyzers and reagents. The reagent segment dominates the market. Blood grouping, cross-matching, and the screening process depend on reagents; hence, it gains the domination power. Increased incidence of hematological disease in the patient population, together with the frequency of blood transfusions, has highly demanded that blood banks depend upon the blood banking reagent kits having increased accuracy levels in the reagent kits. Widespread usage in hospitals, blood banks, and diagnostic laboratories for ensuring compatibility in blood transfusions and managing hemolytic diseases has emphasized the importance of these reagents. The analyzers segment is expected to grow the fastest during the forecast period. This is due to the growing demand for automated & semi-automated analyzers that offer better precision, quicker turnaround times, and efficient workflow in blood testing procedures. The global trend towards automation in laboratories has been one of the most significant factors driving the growth of the analyzers segment.

By end use, the immunohematology market is divided into blood banks, hospitals, diagnostic and reference laboratories, and academic and research institutes. Hospitals are the largest segment of the immunohematology market. This is because hospitals are critical in patient care, where blood typing, cross-matching, and transfusion services are often essential during surgery and trauma. Hospitals also have modern diagnostic facilities and skilled personnel who can perform intricate immunohematology tests for patient management. The blood banks segment is projected to exhibit the highest CAGR during the forecast period. This is mainly due to heightened awareness and associated programs encouraging people to opt for voluntary donations, followed by an expansion of blood banks and collection centers. Blood banks have become unavoidable as they constitute and sustain a secured adequate supply and need to avail themselves of the latest immunohematology in their operations to detect infections while being compatible. Development in blood banks- especially in third-world countries, allows for increased penetration of safe blood transfusions, further propelling market growth.

Immunohematology Market- Geographical Insights

The North American market dominates, having a substantial presence. Advanced infrastructure of healthcare delivery systems and maximum utilization of technology with significant amounts of transfusion per annum explain the share here. The United States is claimed to transfuse an average of around 14.6 million units every year in blood as transcribed by the CDC, marking this region very highly for requiring products and services related to immunohematology. Leading nations contributing to this market include the US & Canada, known for their solid healthcare systems and continuous investment in medical innovations. The Asia-Pacific region is expected to experience the fastest growth during the forecast period. This is due to propelling healthcare expenditure, increased awareness regarding blood donation, and increased blood-related disorders. Countries such as India & China have recently improved their health infrastructure & blood transfusion services, with the WHO observing that such changes are increasing. These trends put countries like China, India, and Japan at the forefront of this growing market and are likely to continue with much improvement in the practice of immunohematology.

Immunohematology Market- Competitive Landscape:

The global immunohematology market is highly competitive, with the presence of a few key players who are driving innovation and expanding their market footprint. The leading companies in the market include Bio-Rad Laboratories, Inc., Immucor, Ortho Clinical Diagnostics, Grifols, and BD (Becton Dickinson), which have dominated the market due to their extensive product portfolios & robust distribution networks. These players focus on developing advanced immunohematology solutions, such as automated analyzers, reagents, and molecular diagnostics, to enhance diagnostic accuracy & efficiency. Strategic collaborations, mergers, and acquisitions are common strategies used to expand product offerings and penetrate emerging markets. Companies are also able to provide increasing markets in Asia-Pacific and Latin America by partnering with healthcare institutions and blood banks. Investments in research and development, aiming to develop new-generation immunohematology technologies, add to the market's competitive landscape. This dynamic environment is likely to propel further developments in the immunohematology sector.

Recent Developments:

April 2024: Grifols launched the Erytra Eflexis automated blood-typing technology in the Chinese market after approval from the appropriate authorities. It automates processes in blood typing and enhances efficiency at blood banks.

May 2023: Bio-Rad Laboratories, Inc. launched the IH-500TM NEXT System, an automated ID-Card system. The system is an improvement of blood type testing sensitivity as well as screening for antibodies.

November 2023: Versiti bought Pearl Pathways, a Indianapolis-based blood management software company. This will help Versiti improve their digital capabilities and better manage the blood supply chain.

July 2023: QuidelOrtho partners with BYG4lab to enrich its Informatics Offerings. The collaboration will focus on creating new software products for blood banks and transfusion centers.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOHEMATOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Bio-Rad Laboratories, Inc.
Immucor
Ortho Clinical Diagnostics
Grifols
BD (Becton Dickinson)
Hologic, Inc.
Siemens Healthineers
ThermoFisher
Abbott
Beckman Coulter, Inc.

GLOBAL IMMUNOHEMATOLOGY MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

Analyzers
Reagents

GLOBAL IMMUNOHEMATOLOGY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Antibody Screening
Blood Typing

GLOBAL IMMUNOHEMATOLOGY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

Blood Banks
Hospitals
Diagnostic and Reference Laboratories
Academic and Research Institutes

GLOBAL IMMUNOHEMATOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Immunohematology Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Immunohematology Market Snippet By Type
- 2.1.2. Immunohematology Market Snippet by Application
- 2.1.3. Immunohematology Market Snippet By End User
- 2.1.4. Immunohematology Market Snippet by Country
- 2.1.5. Immunohematology Market Snippet by Region
2.2. Competitive Insights

3. Immunohematology Key Market Trends

3.1. Immunohematology Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Immunohematology Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Immunohematology Market Opportunities
3.4. Immunohematology Market Future Trends

4. Immunohematology Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Immunohematology Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Immunohematology Market Landscape

6.1. Immunohematology Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Immunohematology Market - By Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
- 7.1.2. Analyzers
- 7.1.3. Reagents

8. Immunohematology Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 8.1.2. Antibody Screening
- 8.1.3. Blood Typing

9. Immunohematology Market - By End User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
- 9.1.2. Blood Banks
- 9.1.3. Hospitals
- 9.1.4. Diagnostic and Reference Laboratories
- 9.1.5. Academic and Research Institutes

10. Immunohematology Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Immunohematology Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Immunohematology Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.8. UK
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.9. France
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.10. Italy
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.11. Spain
  - 10.3.11.1. Overview
  - 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.12. The Netherlands
  - 10.3.12.1. Overview
  - 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Overview
  - 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.14. Russia
  - 10.3.14.1. Overview
  - 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.15. Poland
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.3.16. Rest of Europe
  - 10.3.16.1. Overview
  - 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Immunohematology Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.7. China
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.8. India
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.12. Indonesia
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.13. Thailand
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. Immunohematology Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. Immunohematology Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.8. UAE
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Immunohematology Industry

11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Bio-Rad Laboratories, Inc.
- 11.2.2. Immucor
- 11.2.3. Ortho Clinical Diagnostics
- 11.2.4. Grifols
- 11.2.5. BD (Becton Dickinson)
- 11.2.6. Hologic, Inc.
- 11.2.7. Siemens Healthineers
- 11.2.8. ThermoFisher
- 11.2.9. Abbott
- 11.2.10. Beckman Coulter, Inc.